Kalaris Therapeutics, Inc. (KLRS)
2.12
+0.12
(+6.00%)
USD |
NASDAQ |
Nov 03, 13:30
Kalaris Therapeutics Price : 2.12 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 2.06 | 2.07 | 1.92 | 2.00 | 59274.00 |
| Oct 30, 2026 | 2.08 | 2.08 | 1.965 | 2.03 | 60195.00 |
| Oct 29, 2026 | 2.05 | 2.161 | 2.05 | 2.13 | 23172.00 |
| Oct 28, 2026 | 1.86 | 2.02 | 1.86 | 2.01 | 47611.00 |
| Oct 27, 2026 | 1.78 | 1.875 | 1.78 | 1.86 | 51127.00 |
| Oct 26, 2026 | 1.895 | 1.90 | 1.78 | 1.80 | 36033.00 |
| Oct 23, 2026 | 1.99 | 1.99 | 1.87 | 1.87 | 25406.00 |
| Oct 22, 2026 | 2.01 | 2.04 | 1.95 | 1.99 | 43430.00 |
| Oct 21, 2026 | 2.00 | 2.182 | 1.95 | 2.02 | 84364.00 |
| Oct 20, 2026 | 1.90 | 2.10 | 1.90 | 2.07 | 51409.00 |
| Oct 19, 2026 | 2.04 | 2.04 | 1.867 | 1.91 | 271527.0 |
| Oct 16, 2026 | 2.25 | 2.292 | 2.00 | 2.00 | 58401.00 |
| Oct 15, 2026 | 2.20 | 2.225 | 2.10 | 2.19 | 56980.00 |
| Oct 14, 2026 | 2.22 | 2.23 | 2.11 | 2.13 | 20954.00 |
| Oct 13, 2026 | 2.27 | 2.295 | 2.20 | 2.23 | 73254.00 |
| Oct 12, 2026 | 2.37 | 2.37 | 2.22 | 2.26 | 122092.0 |
| Oct 09, 2026 | 2.46 | 2.55 | 2.36 | 2.36 | 104426.0 |
| Oct 08, 2026 | 2.60 | 2.60 | 2.35 | 2.50 | 109961.0 |
| Oct 07, 2026 | 2.59 | 2.693 | 2.53 | 2.56 | 74117.00 |
| Oct 06, 2026 | 2.90 | 2.93 | 2.61 | 2.66 | 103434.0 |
| Oct 05, 2026 | 2.72 | 2.89 | 2.58 | 2.83 | 27389.00 |
| Oct 02, 2026 | 2.90 | 2.90 | 2.51 | 2.70 | 235897.0 |
| Oct 01, 2026 | 2.88 | 2.89 | 2.76 | 2.85 | 58622.00 |
| Sep 30, 2026 | 2.87 | 2.97 | 2.75 | 2.89 | 102557.0 |
| Sep 29, 2026 | 2.84 | 2.91 | 2.835 | 2.90 | 51803.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Replimune Group, Inc. | 20.25 |
| Arrowhead Pharmaceuticals, Inc. | 60.20 |
| Oncolytics Biotech, Inc. | 0.3937 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 18.57 |
Price Related Metrics
| Price to Book Value | 0.8750 |
| Earnings Yield | -95.00% |
| Market Cap | 50.47M |